relapsed pediatric all
Showing 1 - 6 of 6
Relapsed Pediatric ALL, Acute GVHD (Gvhd) Grade IV (Diagnosis), Relapsed Pediatric AML Trial (In Vitro T cells depletion using
Recruiting
- Relapsed Pediatric ALL
- +2 more
- In Vitro T cells depletion using CliniMCAS system
-
Shanghai, ChinaShanghai Children's Medical Center
Sep 28, 2022
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL, Relapsed Pediatric ALL Trial in Calgary, Edmonton (autologous CD19-directed
Recruiting
- Relapsed Non Hodgkin Lymphoma
- +2 more
- autologous CD19-directed chimeric antigen receptor (CAR) T-cells
-
Calgary, Alberta, Canada
- +5 more
Jul 18, 2022
Relapsed Pediatric ALL, Relapsed Pediatric AML, Refractory Acute Myeloid Leukemia Trial in Kansas City (Daunorubicin)
Recruiting
- Relapsed Pediatric ALL
- +3 more
-
Kansas City, MissouriChildren's Mercy Hospital
Jul 1, 2022
Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia Trial in China (pCAR-19B cells)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- pCAR-19B cells
-
Beijing, Beijing, China
- +9 more
May 19, 2022
Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia Trial in Wuhan (pCAR-19B cells)
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- pCAR-19B cells
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Mar 16, 2022
Recurrent Pediatric ALL, Relapsed Pediatric ALL, Acute Lymphoblastic Leukemia Trial in United States (ABT-751, Dexamethasone,
Terminated
- Recurrent Pediatric ALL
- +3 more
- ABT-751
- +7 more
-
Los Angeles, California
- +4 more
Feb 22, 2021